📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Development and Validation of a New BAG-1L-Specific Antibody to Quantify BAG-1L Protein Expression in Advanced Prostate Cancer. (2023)

First Author: Neeb A

Attributed to: Elucidating how Dysbiosis, Senescence and Inflammatory Storms Impact Prostate Carcinogenesis and Treatment Resistance to Transform Care. funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.labinv.2023.100245

PubMed Identifier: 37652207

Publication URI: http://europepmc.org/abstract/MED/37652207

Type: Journal Article/Review

Volume: 103

Parent Publication: Laboratory investigation; a journal of technical methods and pathology

Issue: 11

ISSN: 0023-6837